PAUL E HANNA
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology MILWAUKEE, WI NPI 1679005201
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology WI NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$397.47
- Category: General Payments
- Program years: PY2024
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $397.47 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $397.47 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $288.37 | 4 |
| Amgen Inc. | $87.19 | 2 |
| CALLIDITAS THERAPEUTICS US INC. | $21.91 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $397.47 | 7 |
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086950597 | Novartis Pharmaceuticals Corporation | $6.14 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086950613 | Novartis Pharmaceuticals Corporation | $135.86 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086950615 | Novartis Pharmaceuticals Corporation | $129.82 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086950623 | Novartis Pharmaceuticals Corporation | $16.55 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117572535 | Amgen Inc. | $34.88 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117572579 | Amgen Inc. | $52.31 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141521503 | CALLIDITAS THERAPEUTICS US INC. | $21.91 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.